[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"trichotillomania\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:trichotillomania":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,47,74,98],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":32,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":4},"100614682","phase-2-semaglutide-wegovy-treatment-for-trichotillomania-100614682",false,"NCT07282769","Semaglutide (Wegovy) Treatment for Trichotillomania","Once Weekly Semaglutide Treatment of Trichotillomania: An Open-Label Study","Inclusion Criteria:\n\n1. Men and women age 18-75;\n2. Diagnosis of current trichotillomania based on DSM-5 criteria and confirmed using the clinician-administered MIDI (13);\n3. Hair pulling daily with urges to pull as the trigger in \\>50% of the episodes of pulling;\n4. Women of childbearing age are required to have a negative result on a beta-human chorionic gonadotropin pregnancy test;\n5. Women of childbearing potential utilizing a medically accepted form of contraception defined as double barrier, oral contraceptive, injectable contraceptive, implantable contraceptive devices, and abstinence\n\nExclusion Criteria:\n\n1. Infrequent pulling (i.e. less than daily) or automatic pulling (i.e. no urges to pull);\n2. Unstable medical illness or clinically significant abnormalities on laboratory tests, EKG, or physical examination at screen as determined by the investigator;\n3. History of seizures;\n4. Myocardial infarction within 6 months;\n5. Current pregnancy or lactation, or inadequate contraception in women of childbearing potential;\n6. A need for medication other than semaglutide with possible psychotropic effects or unfavorable interactions as determined by the investigator;\n7. Clinically significant suicidality (defined by the Columbia Suicide-Severity Rating Scale);\n8. Lifetime history of bipolar disorder type I or II, schizophrenia, or any psychotic disorder;\n9. Current skin picking disorder;\n10. Initiation of psychotherapy or behavior therapy within 3 months prior to study baseline;\n11. Initiation of psychotropic medications within 3 months prior to study baseline (stable doses will be allowed);\n12. Previous treatment with semaglutide;\n13. Use of any weight loss medications;\n14. Body mass index (BMI, calculated as weight in kilograms divided by height in meters squared) less than 23;\n15. Past-year substance use disorder other than tobacco use disorder or mild cannabis use disorder;\n16. Recent (30-day) use of illicit drugs except cannabis;\n17. History of diabetes, and current medical or neurological illness precluding participation based on physician judgment;\n18. Personal or family history of medullary thyroid cancer or multiple endocrine neoplasia 2A or 2B;\n19. History of pancreatitis.","ALL","18 Years","75 Years",{"count":20,"type":21},10,"ESTIMATED","INTERVENTIONAL",[24],"PHASE2","This research study is testing the effectiveness and safety of semaglutide (Wegovy) in people with trichotillomania, also known as hair-pulling disorder.",[27,28,29,30,31],"Trichotillomania (Hair-Pulling Disorder)","Trichotillomania","Hair Pulling Disorder","Hair Pulling","Hair-Pulling Disorder",[33,34],"trichotillomania","hair pulling","NOT_YET_RECRUITING","2026-06-08",{"date":38,"type":39},"2026-06-10","ACTUAL",{"date":41,"type":21},"2026-06",{"date":43,"type":21},"2027-02",{"name":45,"class":46},"University of Chicago","OTHER",{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":51,"acronym":4,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":53,"targetDuration":4,"studyType":22,"phases":55,"briefSummary":57,"conditions":58,"keywords":59,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":73},"100448375","technology-assisted-treatment-for-trichotillomania-100448375","NCT05118633","Technology Assisted Treatment for Trichotillomania","Inclusion Criteria:\n\n1. 18 years of age or older (criterion 1a) with a diagnosis of TTM focused on primary hair pulling location(s) above the neck (e.g., scalp, eyebrows, eye lashes, beard) (criterion 1b).\n2. English language fluency (criterion 2).\n3. Report no current pharmacological intervention targeting TTM symptoms OR a 6-week course of the intervention without change in dosage and intent for that dosage to remain stable for the 12 weeks of this trial (criterion 3a).\n4. Report no current psychosocial intervention targeting TTM (criterion 3b)\n\n4\\. Reliable and consistent access to the internet and\u002For mobile device permitting the participant to meet with someone virtually for 90 min.\n\n5\\. Owns a mobile phone running on Apple's operating system (iOS 6+) 6. Identifies a support person that is able to be contacted if an emergency arises.\n\nExclusion Criteria:\n\n1. Current suicidal\u002Fhomicidal ideation, intent, or plan (criterion 1a) or a diagnosis of another psychiatric condition that may impede a participant's ability to fully utilize the app (e.g., psychotic disorder, eating disorder, moderate to severe major depressive disorder \\[defined by meeting diagnostic criteria on the MINI and a score \\>13 on DASS-21\\]) (criterion 1b)\n2. Has not used HabitAware's Keen or Keen2 bracelet in the past 24 months.\n3. Residing outside the United States",{"count":54,"type":21},90,[56],"NA","The investigators are testing two digital health interventions for trichotillomania (TTM), via a randomized trial design.",[28],[29,60,28,61],"Body-Focused Repetitive Behaviors","habit reversal training","RECRUITING","2026-05-29",{"date":65,"type":39},"2026-06-02",{"date":67,"type":39},"2026-05-15",{"date":69,"type":21},"2026-12-31",{"name":71,"class":72},"HabitAware Inc.","INDUSTRY",1,{"id":75,"slug":76,"hasResults":11,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":4,"eligibilityCriteria":80,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":81,"targetDuration":4,"studyType":22,"phases":82,"briefSummary":83,"conditions":84,"keywords":85,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":73},"100610172","technology-assisted-treatment-of-trichotillomania-open-trial-100610172","NCT07224126","Technology Assisted Treatment of Trichotillomania: Open Trial","Technology Assisted Treatment for Trichotillomania: Open Trial","Inclusion Criteria:\n\n* 18 years of age (criterion 1a) with a diagnosis of TTM (criterion 1b)\n* Must reportEnglish as their primary language (criterion 2)\n* Report no current pharmacological or psychosocial intervention targeting TTM symptoms OR a6-week course of either intervention modality without change in frequency,intensity, or dosage (criterion 3)\n* Reliable and consistent access to the internet and\u002For mobile device permitting the participant to meet withsomeone virtually for 90 min.\n* Must report owning\u002Faccess to a mobilephone running on Apple's operating system (iOS)\n* Identifies a support person that is able to be contacted is an emergency arises.\n* Agrees to allow the Kent State research team to share home address, mobile number, andalternate number\u002Femail with HabitAware, Inc., for purposes of mailing Keen2device and setting up Keen2 system.\n\nExclusion Criteria:\n\n* Current suicidal\u002Fhomicidal ideation, intent, or plan\n* a diagnosis of another psychiatric condition that may impeded a participant's ability to fully utilize the app (e.g., psychotic disorder, major depressive disorder)",{"count":20,"type":21},[56],"This open-label feasibility trial evaluates the use of the Keen2 awareness bracelet for adults with trichotillomania (hair-pulling disorder). Participants will use the bracelet for eight weeks. During the first four weeks, they will wear the device and log contextual information (such as emotions, location, and activity) after each detected hair-pulling episode. Based on these data, participants will then receive tailored predictive alerts designed to support use of stimulus control, competing responses, and coping strategies. The study will assess usability, adherence, and changes in self-reported hair-pulling severity and awareness.",[28],[86,87,88,33,89],"hair pulling disorder","BFRB","Body-Focused Repetitive Behavior","trich","2025-11-07",{"date":92,"type":39},"2025-11-10",{"date":94,"type":39},"2025-09-15",{"date":96,"type":21},"2026-01-09",{"name":71,"class":72},{"id":99,"slug":100,"hasResults":11,"nctId":101,"briefTitle":102,"officialTitle":103,"acronym":104,"eligibilityCriteria":105,"healthyVolunteers":11,"sex":16,"minAge":106,"maxAge":107,"enrollmentInfo":108,"targetDuration":4,"studyType":110,"phases":4,"briefSummary":111,"conditions":112,"keywords":113,"overallStatus":62,"whyStopped":4,"lastUpdateSubmitDate":117,"lastUpdatePostDateStruct":118,"startDateStruct":120,"completionDateStruct":122,"leadSponsor":123,"locationsCount":73},"100266437","cognitive-behavioral-group-therapy-for-trichotillomania-hair-pulling-disorder-100266437","NCT02747771","Cognitive Behavioral Group Therapy for Trichotillomania (Hair Pulling Disorder)","The Norwegian Trichotillomania Project","NorTriP","* Inclusion Criteria:\n\n  * Clinical diagnosis of Trichotillomania\n  * Age between 16 and 67\n* Exclusion Criteria:\n\n  * schizophrenia spectrum disorder\n  * substance addiction\n  * severe antisocial, schizotypal, or paranoid personality disorder\n  * severe eating disorder,\n  * ongoing suicidal ideation\n  * pervasive developmental disorder\n  * mental retardation and severe sequelae after brain injury.","16 Years","67 Years",{"count":109,"type":21},150,"OBSERVATIONAL","This study aims at evaluating the effectiveness of group-based cognitive behavioral therapy for trichotillomania at three clinical sites in Norway.",[28],[114,33,34,61,115,116],"effectiveness","acceptance and commitment therapy","cognitive behavioral therapy","2024-03-01",{"date":119,"type":39},"2024-03-05",{"date":121,"type":4},"2013-01-01",{"date":69,"type":21},{"name":124,"class":46},"Oslo University Hospital"]